XTL Biopharmaceuticals LTD balance sheet

At the end of fiscal 2024, XTL Biopharmaceuticals LTD had total assets of $8.6m and shareholders' equity of $5.4m. It held $371,000 in cash against $138,000 of debt: net cash of $233,000.

Balance sheet

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

XTL Biopharmaceuticals LTD: balance sheet, annual
Fiscal year	2024Dec 2024
Cash and equivalents	371
Total current assets	1,340
Goodwill	3,193
Total assets	8,550
Total current liabilities	2,207
Short-term debt	138
Total debt	138
Shareholders' equity	5,435
Net debt (negative = net cash)	−233

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from XTL Biopharmaceuticals LTD's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to XTL Biopharmaceuticals LTD.